Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan
· Delayed Price · Currency is TWD 47.45
-2.65 (-5.29%)
Mar 9, 2026, 1:45 PM CST
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 1.89 billion as of March 9, 2026. Its market cap has decreased by -22.28% in one year.
Market Cap
1.89B
Enterprise Value
1.93B
Revenue
698.11M
Ranking
n/a
PE Ratio
53.47
Stock Price
47.45
Market Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has increased from 1.68B to 1.89B, an increase of 12.21%. That is a compound annual growth rate of 2.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.89B | -24.68% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OK Biotech | 1.98B |
| Taiwan Biomaterial | 1.73B |
| Wellell | 2.30B |
| Rossmax International | 1.68B |
| Dynamic Medical Technologies | 2.37B |
| Cowealth Medical Holding | 1.59B |
| Applied BioCode | 2.53B |
| Bioptik Technology Incorporation | 1.52B |